Page last updated: 2024-10-28

ibuprofen and Adenocarcinoma of Lung

ibuprofen has been researched along with Adenocarcinoma of Lung in 1 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
"Ibuprofen, therefore, is a potential therapeutic agent that might allow lowering the doses of cisplatin and limiting the many challenge associated with its toxicity and development of drug resistance."1.40Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70. ( Endo, H; Kido, H; Okumura, Y; Yano, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, H1
Yano, M1
Okumura, Y1
Kido, H1

Other Studies

1 other study available for ibuprofen and Adenocarcinoma of Lung

ArticleYear
Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70.
    Cell death & disease, 2014, Jan-30, Volume: 5

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplati

2014